Lonza Group Ag Book Value Per Share 2012-2024 | LZAGY
Current and historical book value per share for Lonza Group Ag (LZAGY) from 2012 to 2024. Book value per share can be defined as the amount of equity available to shareholders expressed on a per common share basis. Lonza Group Ag book value per share for the three months ending December 31, 2024 was $0.00.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $52.624B | $7.468B |
| Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.085B | 27.79 |
| Boston Scientific (BSX) | United States | $155.238B | 38.86 |
| Stryker (SYK) | United States | $144.362B | 30.18 |
| EssilorLuxottica (ESLOY) | France | $132.860B | 0.00 |
| Medtronic (MDT) | Ireland | $108.824B | 15.89 |
| Haleon (HLN) | United Kingdom | $48.259B | 27.44 |
| ResMed (RMD) | United States | $35.183B | 26.43 |
| GE HealthCare Technologies (GEHC) | United States | $32.295B | 15.33 |
| Agilent Technologies (A) | United States | $30.971B | 20.46 |
| Terumo (TRUMY) | Japan | $29.019B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.053B | 17.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.255B | 12.80 |
| Insulet (PODD) | United States | $18.084B | 77.18 |
| Baxter (BAX) | United States | $15.752B | 11.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.535B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.447B | 18.31 |
| Bio-Rad Laboratories (BIO) | United States | $6.620B | 22.38 |
| Prestige Consumer Healthcare (PBH) | United States | $4.171B | 19.90 |
| Perrigo (PRGO) | Ireland | $3.497B | 10.01 |
| ICU Medical (ICUI) | United States | $3.486B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.208B | 15.10 |
| Envista Holdings (NVST) | United States | $2.880B | 23.93 |
| GN Store Nord (GNNDY) | Denmark | $2.068B | 17.13 |
| QuidelOrtho (QDEL) | United States | $1.964B | 16.45 |
| LeMaitre Vascular (LMAT) | United States | $1.778B | 39.75 |
| AtriCure (ATRC) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.374B | 21.63 |
| Neogen (NEOG) | United States | $1.248B | 15.97 |
| Kestra Medical Technologies (KMTS) | United States | $1.220B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.200B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.184B | 11.40 |
| InMode (INMD) | Israel | $1.013B | 9.28 |
| Phibro Animal Health (PAHC) | United States | $0.789B | 12.10 |
| Evolus (EOLS) | United States | $0.779B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.637B | 0.00 |
| CeriBell (CBLL) | United States | $0.588B | 0.00 |
| Owens & Minor (OMI) | United States | $0.580B | 4.94 |
| Valneva SE (VALN) | France | $0.549B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.542B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.526B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.458B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.442B | 0.00 |
| Omeros (OMER) | United States | $0.418B | 0.00 |
| Surmodics (SRDX) | United States | $0.395B | 0.00 |
| SNDL (SNDL) | Canada | $0.365B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 15.55 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.296B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.292B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.291B | 26.32 |
| Aurora Cannabis (ACB) | Canada | $0.272B | 48.40 |
| Sanuwave Health (SNWV) | United States | $0.264B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.60 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.245B | 0.00 |
| Quanterix (QTRX) | United States | $0.233B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.231B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| Biote (BTMD) | United States | $0.190B | 4.35 |
| Utah Medical Products (UTMD) | United States | $0.173B | 13.93 |
| Brainsway (BWAY) | Israel | $0.170B | 53.06 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| Organigram Global (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.22 |
| Jin Medical (ZJYL) | China | $0.119B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.108B | 0.00 |
| Agape ATP (ATPC) | $0.099B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.70 |
| Jushi Holdings (JUSHF) | United States | $0.076B | 0.00 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| United Health Products (UEEC) | United States | $0.064B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 61.50 |
| United-Guardian (UG) | United States | $0.037B | 11.28 |
| Safety Shot (SHOT) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |